Wall Street stocks closed lower on Friday despite a slightly better-than-expected US consumption reading. At the close, the Dow Jones Industrial Average was down 0.75% at 44,544.66, while the S&P 500 ...

Live Updates S&P 500 Nears Record High Amid Tech Redemption 1:31 pm Stocks have reclaimed pre-DeepSeek levels as the S&P 500 looks to close out January higher. The S&P 500 is on pace for a 3%-plus ...

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.

Wall Street was moving higher still shortly after the open, on the back of slightly better-than-expected readings for US ...

Shares of Charter Communications, Inc. CHTR +5.52% Get Free Report rose during Friday's session after the company reported ...

Uber and Lyft (NASDAQ: LYFT) shares faced pressure this week following a series of autonomous vehicle (AV) developments, including Tesla’s plans for self-drivin ...

Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.

Vertex Pharmaceuticals announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Broadcom’s business relies heavily on their networking products, which are crucial for data transfer in AI systems. If the market for premium AI chips experiences a downturn, amid the rise of DeepSeek ...

Vertex Pharmaceuticals Incorporated will report its fourth quarter and full year 2024 financial results on Monday, February 10, 2025 after the financial markets close. The company will host a ...